{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:37:05Z","timestamp":1780468625086,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2393-14-87","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T12:02:28Z","timestamp":1393329748000},"source":"Crossref","is-referenced-by-count":59,"title":["Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHDgenotyping and a review of policy and practice"],"prefix":"10.1186","volume":"14","author":[{"given":"Julie","family":"Kent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Maree","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Soothill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"977_CR1","unstructured":"Of 723,913 births in England and Wales 2011, 15% (108,000) were rhesus negative births: http:\/\/www.ons.gov.uk\/ons\/rel\/vsob1\/birth-summary-tables--england-and-wales\/2011--final-\/sb-births-and-deaths-in-england-and-wales--2011--final-.html ,"},{"key":"977_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","volume":"336","author":"K Finning","year":"2008","unstructured":"Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G: Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ. 2008, 336: 816-818. 10.1136\/bmj.39518.463206.25.","journal-title":"BMJ"},{"key":"977_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-3148.2008.00882.x","volume":"18","author":"M Harkness","year":"2008","unstructured":"Harkness M, Freer Y, Prescott RJ, Warner P: Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units. Transfus Med. 2008, 18: 292-295. 10.1111\/j.1365-3148.2008.00882.x.","journal-title":"Transfus Med"},{"key":"977_CR4","volume-title":"Routine antenatal anti-D prophylaxis for women who are rhesus D negative","author":"National Institute for Health and Clinical Excellence","year":"2008","unstructured":"National Institute for Health and Clinical Excellence: Routine antenatal anti-D prophylaxis for women who are rhesus D negative. 2008, Review of NICE technology appraisal guidance 41"},{"key":"977_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/1471-0528.12175","volume":"120","author":"PHB Bolton-Maggs","year":"2013","unstructured":"Bolton-Maggs PHB, Davies T, Poles D, Cohen J: Errors in anti-D immunoglobulin administration: retrospective analysis of 15\u00a0years of reports to the UK confidential haemovigilance scheme. Int J Obstet Gynaecol. 2013, 120: 873-878. 10.1111\/1471-0528.12175.","journal-title":"Int J Obstet Gynaecol"},{"key":"977_CR6","first-page":"4","volume-title":"Green-top Guideline 22 The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis","author":"See Royal College Obstetricians & Gynaecologists (RCOG)","year":"2011","unstructured":"See Royal College Obstetricians & Gynaecologists (RCOG): Green-top Guideline 22 The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis. 2011, \u201cIt should be noted that anti-D Ig does not protect against the development of other antibodies which can cause haemolytic disease of the newborn\u201d, 4- http:\/\/www.rcog.org.uk\/womens-health\/clinical-guidance\/use-anti-d-immunoglobulin-rh-prophylaxis-green-top-22 ,"},{"key":"977_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW: Wainscoat JS: presence of fetal DNA in maternal plasma and serum. Lancet. 1997, 350: 485-487. 10.1016\/S0140-6736(97)02174-0.","journal-title":"Lancet"},{"key":"977_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1046\/j.1537-2995.2002.00165.x","volume":"42","author":"KM Finning","year":"2002","unstructured":"Finning KM, Martin PG, Soothill PW, Avent ND: Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002, 42: 1079-1085. 10.1046\/j.1537-2995.2002.00165.x.","journal-title":"Transfusion"},{"key":"977_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/tmrv.2003.50001","volume":"17","author":"V der Schoot","year":"2003","unstructured":"der Schoot V, Tax C, Robbert J, Rijnders J, de Hass M, Christiaens : Prenatal typing of RH & Kell Blood group system antigens: the edge of a watershed. Transfus Med Rev. 2003, 17: 31-44. 10.1053\/tmrv.2003.50001.","journal-title":"Transfus Med Rev"},{"key":"977_CR10","first-page":"185","volume-title":"Methods in Molecular Biology","author":"N Avent","year":"2008","unstructured":"Avent N: RhD Genotyping from maternal plasma: guidelines and technical challenges. Methods in Molecular Biology. Edited by: Hahn S, Jackson L. 2008, Totowa NJ: Humana Press, 185-201."},{"key":"977_CR11","volume-title":"Scottish National Clinical Guidance","author":"Pregnant Women with Red Cell Antibodies","year":"2013","unstructured":"Pregnant Women with Red Cell Antibodies: Scottish National Clinical Guidance. 2013, http:\/\/www.scotblood.co.uk\/about-us\/publications.aspx ,"},{"key":"977_CR12","unstructured":"National Comparative Audit of Blood Transfusion. http:\/\/www.uhbristol.nhs.uk\/patients-and-visitors\/your-hospitals\/st-michaels-hospital\/what-we-do\/fetal-medicine-unit\/rhesus-negative-ffdna-pilot ,"},{"issue":"4","key":"977_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1537-2995.2011.03362.x","volume":"52","author":"FB Clausen","year":"2011","unstructured":"Clausen FB, Christiansen M, Steffensen R, J\u00f8rgensen S, Nielsen C, Jakobsen MA, Madsen RD, Jensen K, Krog GR, Rieneck k, Sprog\u00f8e U, Homburg KM, Grunnet N, Dziegiel MH: Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion. 2011, 52 (4): 752-758.","journal-title":"Transfusion"},{"key":"977_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1751-2824.2012.01600.x","volume":"7","author":"M de Haas","year":"2012","unstructured":"de Haas M, van der Ploeg C, Scheffer PG, Verlinden DA, Hirshberg H, Abbink F, van der Schoot CE: A nationwide fetal RHD screening programme for targeted antenatal and postnatal anti-D. International Society of Blood Transfusion, ISBT Science Series. 2012, 7: 164-167. 10.1111\/j.1751-2824.2012.01600.x.","journal-title":"International Society of Blood Transfusion, ISBT Science Series"},{"key":"977_CR15","doi-asserted-by":"crossref","unstructured":"Kent J, Farrell AM: Risky bodies in the plasma bioeconomy: a feminist analysis. Body & Society. in press","DOI":"10.1177\/1357034X13520331"},{"key":"977_CR16","volume-title":"Report of the Tribunal of Inquiry into The Blood Transfusion Service Board","author":"Finlay, the Honourable Mr Justice T","year":"1997","unstructured":"Finlay, the Honourable Mr Justice T: Report of the Tribunal of Inquiry into The Blood Transfusion Service Board. 1997, Dublin: Stationery Office"},{"key":"977_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0168-8278(96)80126-7","volume":"25","author":"E Schreier","year":"1996","unstructured":"Schreier E, Hohne M, Kunkel U, Berg T, Hopf U: Hepatitis GBV-C sequences in patients infected with HCV, contaminated Anti-D immunoglobulin and among i.v. drug users in Germany. J Hepatol. 1996, 25: 385-389. 10.1016\/S0168-8278(96)80126-7.","journal-title":"J Hepatol"},{"key":"977_CR18","unstructured":"RCOG. 2011, 8-op cit see note 6 above"},{"key":"977_CR19","volume-title":"op cit see note 5 above","author":"Bolton\u2013Maggs","year":"2013","unstructured":"Bolton\u2013Maggs, et al: op cit see note 5 above. 2013, http:\/\/www.shotuk.org\/home ,"},{"key":"977_CR20","volume-title":"Better Blood Transfusion Safe and Appropriate Use of Blood HSC 2007\/001","author":"Department of Health","year":"2007","unstructured":"Department of Health: Better Blood Transfusion Safe and Appropriate Use of Blood HSC 2007\/001. 2007, Department of Health"},{"key":"977_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2393-11-5","volume":"11","author":"A Szczepura","year":"2011","unstructured":"Szczepura A, Osipenko L, Freeman K: A new fetal RhD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales. BMC Pregnancy Childbirth. 2011, 11: 5-10.1186\/1471-2393-11-5.","journal-title":"BMC Pregnancy Childbirth"},{"key":"977_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tracli.2006.02.021","volume":"13","author":"C Van der Schoot","year":"2006","unstructured":"Van der Schoot C, Ait Soussan A, Koelewijn J, Bonsel L, Paget-Christiaens L, de Haas M: Non Invasive antenatal RHD typing. Transfus Clin Biol. 2006, 13: 53-57. 10.1016\/j.tracli.2006.02.021.","journal-title":"Transfus Clin Biol"},{"key":"977_CR23","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139047968","volume-title":"The Politics of Blood. Ethics, Innovation and the Regulation of Risk","author":"AM Farrell","year":"2012","unstructured":"Farrell AM: The Politics of Blood. Ethics, Innovation and the Regulation of Risk. 2012, Cambridge: CambridgeUniversity Press"},{"key":"977_CR24","unstructured":"Rhesus negative ffDNA pilot. See http:\/\/hospital.blood.co.uk\/safe_use\/clinical_audit\/national_comparative (last accessed 17th February 2014)."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-14-87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-14-87\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-14-87","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T08:32:58Z","timestamp":1498120378000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-14-87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-14-87","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,25]]},"article-number":"87"}}